Cargando…
Cancer nanomedicine
The field of cancer nanomedicine seeks to overcome the inherent shortcomings of conventional cancer diagnostics and therapies. Yet despite the surge of interest in and attractive attributes of nanotechnologies, challenges remain in their clinical translation, prompting some to argue that they have n...
Autores principales: | Bhatia, Sangeeta N., Chen, Xiaoyuan, Dobrovolskaia, Marina A., Lammers, Twan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9358926/ https://www.ncbi.nlm.nih.gov/pubmed/35941223 http://dx.doi.org/10.1038/s41568-022-00496-9 |
Ejemplares similares
-
The EPR effect and beyond: Strategies to improve tumor targeting and cancer nanomedicine treatment efficacy
por: Shi, Yang, et al.
Publicado: (2020) -
Challenges in nanomedicine clinical translation
por: Metselaar, Josbert M., et al.
Publicado: (2020) -
Nanomedicine formulations for combination therapies
por: Lammers, Twan, et al.
Publicado: (2010) -
Nanomedicine: making controllable magnetic drug delivery possible for the treatment of breast cancer
por: Tran, Lesa A, et al.
Publicado: (2011) -
Roadmap and strategy for overcoming infusion reactions to nanomedicines
por: Szebeni, Janos, et al.
Publicado: (2018)